News
 

Current news - Archive

PanaMEA – intelligent blood sugar level monitoring

June 29, 2020

The aim of the BMBF-funded project is the development of an intelligent implant to measure blood sugar levels up to the in vivo proof of concept.
The electrical activity of the islets of Langerhans in the pancreas is a measure for the blood sugar level and is to be measured in the body by means of an ASIC
IMS CHIPS will be responsible for the development and sample production of this ASIC.

Additional project partners:

  • mfd Diagnostics GmbH, Wendelsheim (project management)
  • CorTec GmbH, Freiburg
  • PFÜTZNER Science & Health Institute GmbH, Mainz
  • NMI - Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen
  • University Hospital Tübingen. University Hospital for General, Visceral and Transplant Surgery, Tübingen


Funded by the BMBF
Funding code: 13GW0397F
Project timetable: April 1st, 2020 thru March 30th, 2023